Cargando…
Identification of Potential Antigens for Developing mRNA Vaccine for Immunologically Cold Mesothelioma
Messenger RNA vaccines are considered to be a promising strategy in cancer immunotherapy, while their application on mesothelioma is still largely uncharacterized. This study aimed to identify potential antigens in mesothelioma for anti-mesothelioma mRNA vaccine development, and further determine th...
Autores principales: | Zhang, Shichao, Li, Shuqin, Wei, Ya, Xiong, Yu, Liu, Qin, Hu, Zuquan, Zeng, Zhu, Tang, Fuzhou, Ouyang, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284534/ https://www.ncbi.nlm.nih.gov/pubmed/35846349 http://dx.doi.org/10.3389/fcell.2022.879278 |
Ejemplares similares
-
LRP2 and DOCK8 Are Potential Antigens for mRNA Vaccine Development in Immunologically ‘Cold’ KIRC Tumours
por: Zhang, Shichao, et al.
Publicado: (2023) -
Crosstalk Between Four Types of RNA Modification Writers Characterizes the Tumor Immune Microenvironment Infiltration Patterns in Skin Cutaneous Melanoma
por: Zhang, Shichao, et al.
Publicado: (2022) -
Identification of Tumor Antigens and Immune Subtypes in Lung Adenocarcinoma for mRNA Vaccine Development
por: Xu, Ran, et al.
Publicado: (2022) -
Identification of Tumor Antigens and Design of mRNA Vaccine for Colorectal Cancer Based on the Immune Subtype
por: Liu, Cong, et al.
Publicado: (2022) -
Identification of tumor antigens and immune subtypes in head and neck squamous cell carcinoma for mRNA vaccine development
por: Chen, Yan, et al.
Publicado: (2022)